Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons

Psychology, Health and Medicine

Volumn 22, Issue 3, 2017, Pages 289-302

  Okafor, Chukwuemeka N ^a   Kelso, Natalie E ^a   Bryant, Vaughn ^b   Burrell, Larry E ^b   Míguez, Maria Jose ^c   Gongvatana, Assawin ^d   Tashima, Karen T ^e   de la Monte, Suzanne ^e   Cook, Robert L ^a   Cohen, Ronald A ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

body mass index; cytokines; HIV; inflammation; neurocognition

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN DERIVATIVE;

ADULT; BLOOD; BODY MASS; COGNITIVE DEFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; OBESITY; PSYCHOLOGY;

ADULT; BIOMARKERS; BODY MASS INDEX; COGNITION DISORDERS; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; OBESITY;

EID: 84975229376     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548506.2016.1199887     Document Type: Article

References (60)

1. Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., … Wojna, V. E., (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69, 1789–1799. 10.1212/01.WNL.0000287431.88658.8b
2. Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J., (1998). Hopkins verbal learning test–revised:Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist (Neuropsychology, Development and Cognition:Section D), 12, 43–55. 10.1076/clin.12.1.43.1726
3. Benedict, R. H. B., Schretlen, D., Groninger, L., Dobraski, M., & Shpritz, B., (1996). Revision of the brief visuospatial memory test:Studies of normal performance, reliability, and validity. Psychological Assessment, 8, 145–153. 10.1037/1040-3590.8.2.145
4. Benton, A. L., Hamsher, K. deS., & Sivan, A. B., 1994. Multilingual Aphasia Examination. (3rd ed.). Iowa City, IA:AJA Associates.
5. Childs, E. A., Lyles, R. H., Selnes, O. A., Chen, B., Miller, E. N., Cohen, B. A., … McArthur, J. C., (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52, 607–613.10.1212/WNL.52.3.607
6. Cohen, R. A., de la Monte, S., Gongvatana, A., Ombao, H., Gonzalez, B., Devlin, K. N., … Tashima, K. T., (2011). Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning. Journal of Neuroimmunology, 233, 204–210. 10.1016/j.jneuroim.2010.11.006
7. Correia, S., Cohen, R., Gongvatana, A., Ross, S., Olchowski, J., Devlin, K., … Delamonte, S., (2013). Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV. Journal of Neuroimmunology, 265(1–2), 117–123. http://doi.org/10.1016/j.jneuroim.2013.09.005
8. Cottam, D. R., Mattar, S. G., Barinas-Mitchell, E., Eid, G., Kuller, L., Kelley, D. E., & Schauer, P. R., (2004). The chronic inflammatory hypothesis for the morbidity associated with morbid obesity:Implications and effects of weight loss. Obesity Surgery, 14, 589–600. 10.1381/096089204323093345
9. Crum-Cianflone, N., Roediger, M. P., Eberly, L., Headd, M., Marconi, V., Ganesan, A., … Agan, B. K., Infectious Disease Clinical Research Program HIV Working Group. (2010). Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS ONE, 5, e10106. 10.1371/journal.pone.0010106
10. Dahl, A. K., & Hassing, L. B., (2013). Obesity and cognitive aging. Epidemiologic Reviews, 35(1), 22–32. http://doi.org/10.1093/epirev/mxs002
11. Dahl, A., Hassing, L. B., Fransson, E., Berg, S., Gatz, M., Reynolds, C. A., & Pedersen, N. L., (2010). Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. The Journals of Gerontology Series A:Biological Sciences and Medical Sciences, 65A, 57–62. 10.1093/gerona/glp035
12. Dahl, A. K., Hassing, L. B., Fransson, E. I., Gatz, M., Reynolds, C. A., & Pedersen, N. L., (2013). Body mass index across midlife and cognitive change in late life. International Journal of Obesity, 37, 296–302. 10.1038/ijo.2012.37
13. Devlin, K. N., Gongvatana, A., Clark, U. S., Chasman, J. D., Westbrook, M. L., Tashima, K. T., … Cohen, R. A., (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. Journal of the International Neuropsychological Society, 18, 68–78. 10.1017/S1355617711001408
14. Fantuzzi, G., 2005. Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology, 115, 911–919; quiz 920. 10.1016/j.jaci.2005.02.023
15. Ferrando, S., van Gorp, W., McElhiney, M., Goggin, K., Sewell, M., & Rabkin, J., (1998). Highly active antiretroviral treatment in HIV infection. AIDS, 12, F65–F70.10.1097/00002030-199808000-00002
16. Fialho, R., Pereira, M., Bucur, M., Fisher, M., Whale, R., & Rusted, J., (2015). Cognitive impairment in HIV and HCV co-infected patients:A systematic review and meta-analysis. AIDS Care, 1–14. 10.1080/09540121.2015.1108385
17. Fialho, R. M., Pereira, M., Mendonça, N., & Ouakinin, S., (2013). Depressive symptoms and neurocognitive performance among HIV-infected women. Women and Health, 53, 117–134. 10.1080/03630242.2013.767301
18. Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., … Scarpini, E., (2006). Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease. Neurobiology of Aging, 27, 1763–1768. 10.1016/j.neurobiolaging.2005.10.007
19. Golden, C. J., & Freshwater, S. M., (2002). Stroop Color and Word Test:Revised examiner’s manual. Wood Dale, IL:Stoelting.
20. Grant, I., (2008). Neurocognitive disturbances in HIV. International Review of Psychiatry, 20, 33–47. 10.1080/09540260701877894
21. Gregor, M. F., & Hotamisligil, G. S., (2011). Inflammatory mechanisms in obesity. Annual Review of Immunology, 29, 415–445. 10.1146/annurev-immunol-031210-101322
22. Gunstad, J., Lhotsky, A., Wendell, C. R., Ferrucci, L., & Zonderman, A. B., (2010). Longitudinal examination of obesity and cognitive function:Results from the Baltimore longitudinal study of aging. Neuroepidemiology, 34, 222–229. 10.1159/000297742
23. Gunstad, J., Paul, R. H., Cohen, R. A., Tate, D. F., Spitznagel, M. B., & Gordon, E., (2007). Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Comprehensive Psychiatry, 48, 57–61. 10.1016/j.comppsych.2006.05.001
24. Gustafson, D. R., Mielke, M. M., Tien, P. C., Valcour, V., Cohen, M., Anastos, K., … Crystal, H. A., (2013). Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The women’s interagency HIV study. Journal of NeuroVirology, 19, 574–585. 10.1007/s13365-013-0219-1
25. Hassing, L. B., Dahl, A. K., Pedersen, N. L., & Johansson, B., (2010). Overweight in midlife is related to lower cognitive function 30 years later:A prospective study with longitudinal assessments. Dementia and Geriatric Cognitive Disorders, 29, 543–552. 10.1159/000314874
26. Hayes, A. F., & Preacher, K. J., (2014). Statistical mediation analysis with a multicategorical independent variable. British Journal of Mathematical and Statistical Psychology, 67, 451–470. 10.1111/bmsp.12028
27. Heaton, R. K., Clifford, D. B., Franklin, D. R., Jr., Woods, S. P., Ake, C., Vaida, F., …, CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy:CHARTER study. Neurology, 75, 2087–2096. 10.1212/WNL.0b013e318200d727
28. Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, H., …, HNRC Group. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. J. Int. Neuropsychol. Soc. JINS, 10, 317–331. 10.1017/S1355617704102130
29. Kim, D. J., Westfall, A. O., Chamot, E., Willig, A. L., Mugavero, M. J., Ritchie, C., … Willig, J. H., (2012). Multimorbidity patterns in HIV-infected patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 61, 600–605. 10.1097/QAI.0b013e31827303d5
30. Kløve, H., (1963). Grooved pegboard. Lafayette, IN:Lafayette Instruments.
31. Lindl, K. A., Marks, D. R., Kolson, D. L., & Jordan-Sciutto, K. L., (2010). HIV-associated neurocognitive disorder:Pathogenesis and therapeutic opportunities. Journal of Neuroimmune Pharmacology, 5, 294–309. 10.1007/s11481-010-9205-z
32. Magaki, S., Mueller, C., Dickson, C., & Kirsch, W., (2007). Increased production of inflammatory cytokines in mild cognitive impairment. Experimental Gerontology, 42, 233–240. 10.1016/j.exger.2006.09.015
33. Mariz, C. de. A., Albuquerque, M. de. F. P. M. de., Ximenes, R. A. de. A., Melo, H. R. L. de., Bandeira, F., Oliveira, T. G. B. E., … Miranda Filho, D. de. B., (2011). Body mass index in individuals with HIV infection and factors associated with thinness and overweight/obesity. Cad. Saúde Pública, 27, 1997–2008.
34. Martin-Thormeyer, E. M., & Paul, R. H., (2009). Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder:Neurocognitive and neuroimaging features. Neuropsychology Review, 19, 215–231. 10.1007/s11065-009-9101-6
35. McCutchan, J. A., Marquie-Beck, J. A., FitzSimons, C. A., Letendre, S. L., Ellis, R. J., Heaton, R. K., …, CHARTER Group. (2012). Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology, 78, 485–492. 10.1212/WNL.0b013e3182478d64
36. Meagher, C., Beilke, J., Arreaza, G., Mi, Q.-S., Chen, W., Salojin, K., … Delovitch, T. L., (2010). Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism. Diabetes, 59, 2862–2871. 10.2337/db09-0131
37. Menza, M., Dobkin, R. D., Marin, H., Mark, M. H., Gara, M., Bienfait, K., … Kusnekov, A., (2010). The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson’s disease. Psychosomatics, 51, 474–479. 10.1176/appi.psy.51.6.474
38. Miller, A. A., & Spencer, S. J., (2014). Obesity and neuroinflammation:A pathway to cognitive impairment. Brain, Behavior, and Immunity, 42, 10–21. 10.1016/j.bbi.2014.04.001
39. Pedersen, K. K., Pedersen, M., Gaardbo, J. C., Ronit, A., Hartling, H. J., Bruunsgaard, H., … Nielsen, S. D., (2013). Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long-term treatment with combination antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 63, 272–279. 10.1097/QAI.0b013e318289bced
40. Radloff, L. S., (1977). The CES-D scale a self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401. 10.1177/014662167700100306
41. Reitan, R. M., (1955). The relation of the trail making test to organic brain damage. Journal of Consulting Psychology, 19(5), 393–394.
42. Sabia, S., Kivimaki, M., Shipley, M. J., Marmot, M. G., & Singh-Manoux, A., (2009). Body mass index over the adult life course and cognition in late midlife:the Whitehall II Cohort Study. American Journal of Clinical Nutrition, 89, 601–607. 10.3945/ajcn.2008.26482
43. Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., … for The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. (2013). Closing the gap:Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE, 8, e81355. 10.1371/journal.pone.0081355
44. Sattler, F., He, J., Letendre, S., Wilson, C., Sanders, C., Heaton, R., … CHARTER Group. (2015). Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. Journal of Acquired Immune Deficiency Syndromes (1999), 68(3), 281–288. http://doi.org/10.1097/QAI.0000000000000458
45. Schram, M. T., Euser, S. M., De Craen, A. J. M., Witteman, J. C., Frölich, M., Hofman, A., … Westendorp, R. G. J., (2007). Systemic markers of inflammation and cognitive decline in old age. Journal of the American Geriatrics Society, 55, 708–716. 10.1111/j.1532-5415.2007.01159.x
46. Sharma, S., & Kavuru, M., (2010). Sleep and metabolism:An overview. International Journal of Endocrinology. 10.1155/2010/270832
47. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., …, Dunbar, G. C., 1998. The mini-international neuropsychiatric interview (M.I.N.I.):The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl. 20), 22–33–57.
48. Singh, R. B., Pella, D., Mechirova, V., & Otsuka, K., (2004). Can brain dysfunction be a predisposing factor for metabolic syndrome? Biomedicine & Pharmacotherapy, 58, S56–S68.
49. Skundric, D. S., Cai, J., Cruikshank, W. W., & Gveric, D., (2006). Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions. Journal of Neuroinflammation, 3, 13. http://doi.org/10.1186/1742-2094-3-13
50. Smith, E., Hay, P., Campbell, L., & Trollor, J. N., (2011). A review of the association between obesity and cognitive function across the lifespan:Implications for novel approaches to prevention and treatment. Obesity Reviews, 12, 740–755. 10.1111/j.1467-789X.2011.00920.x
51. Stanek, K. M., Strain, G., Devlin, M., Cohen, R., Paul, R., Crosby, R. D., … Gunstad, J., (2013). Body mass index and neurocognitive functioning across the adult lifespan. Neuropsychology, 27, 141–151. 10.1037/a0031988
52. Sturman, M. T., de Leon, C. F. M., Bienias, J. L., Morris, M. C., Wilson, R. S., & Evans, D. A., (2008). Body mass index and cognitive decline in a biracial community population. Neurology, 70, 360–367. 10.1212/01.wnl.0000285081.04409.bb
53. Thames, A. D., Arentoft, A., Rivera-Mindt, M., & Hinkin, C. H., (2013). Functional disability in medication management and driving among individuals with HIV:A 1-year follow-up study. Journal of Clinical and Experimental Neuropsychology, 35, 49–58. 10.1080/13803395.2012.747596
54. Waldstein, S. R., & Katzel, L. I., (2006). Interactive relations of central versus total obesity and blood pressure to cognitive function. International Journal of Obesity, 30, 201–207. 10.1038/sj.ijo.0803114
55. Wechsler, D., (1997). Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio, TX:The Psychological Corporation.
56. Woods, S. P., Morgan, E. E., Marquie-Beck, J., Carey, C. L., Grant, I., & Letendre, S. L., (2006). Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cognitive and Behavioral Neurology, 19, 217–221. 10.1097/01.wnn.0000213916.10514.57
57. Obesity and Overweight for Professionals:Adult:Defining–DNPAO–CDC [WWW Document]. n.d. Retrieved September 11, 2014, from http://www.cdc.gov/obesity/adult/defining.html
58. Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., … Harris, T., (2003). Inflammatory markers and cognition in well-functioning African–American and white elders. Neurology, 61, 76–80.10.1212/01.WNL.0000073620.42047.D7
59. Yeni, P., (2006). Update on HAART in HIV. Journal of Hepatology, 44, S100–S103. 10.1016/j.jhep.2005.11.021
60. Yuan, L., Qiao, L., Wei, F., Yin, J., Liu, L., Ji, Y., … Chen, D., (2013). Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. Journal of NeuroVirology, 19, 144–149. 10.1007/s13365-013-0150-5